阿里拉姆制药 ALNY 深 沪
已收盘 09-12 16:00:00 美东时间
465.89
-2.690
-0.57%
华盛通- 最 高475.6899
- 今 开468.29
- 成交量 63.08万股
- 最 低 465.48
- 昨 收 468.58
- 总市值 610.32亿
- 52周最高 484.21
- 市盈率 静 --
- 换手率 0.48%
- 52周最低 205.87
- 委 比 91.24%
- 总股本 1.31亿
- 历史最高 484.21
- 量 比 0.41
- 振 幅 2.18%
- 历史最低 5.879
- 每 手 1
- 风险率 62.32%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Monopar to Present New Long-Term Neurological Efficacy and Safety Data for ALXN1840 in Wilson Disease at the 150th American Neurological Association Annual Meeting
Monopar Therapeutics announced new long-term neurological efficacy and safety data for ALXN1840 in Wilson disease, presented at the 150th ANA Annual Meeting. The analysis included 255 patients for efficacy and 266 for safety, with a median treatment duration of 2.6 years. Key findings: sustained neurological improvement over 6 years, crossover benefit for patients switching from standard of care, significant psychiatric improvement, consistent be...
09-14 12:00
美股异动|辉瑞股价大跌创低位 市场竞争与政策不确定性拖累表现
（来源：美股情报站） 9月12日，辉瑞公司股价下跌3.98%，创下2025年8月以来的新低。这样的市场表现无疑引发了投资者的关注和疑问。最近，辉瑞在与bri...
09-13 06:31
Alnylam Pharma Executes Note Repurchase Transactions
Alnylam Pharma ( ($ALNY) ) has provided an announcement. Alnylam Pharma has eng...
09-13 05:53
CDC to offer contract to study link between vaccines and autism
The U.S. Centers for Disease Control and Prevention (CDC) proposes to offer a contract opportunity to Rensselaer Polytechnic Institute to run a study on a potential link between vaccination and autism...
09-13 00:19
美股大行评级 | 潜在涨幅208.48%！HC Wainwright & Co.上调Microbot Medical目标价至12美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Microbot Medical"买入"评级，目标价从9美元升至12美元；Maxim Group：维持Neuphoria Therapeutics"买入"评级，目标价从18美元升至35美元
09-12 12:53
BridgeBio(BBIO.US)指控辉瑞(PFE.US)、Alnylam(ALNY.US)在数十亿美元心脏病药市场采用“争议策略”竞争
BridgeBio Pharma称其一款心脏病药物疗效更优且成本更低，但同时指控竞争对手在这个价值数十亿美元的市场中采用“有争议的策略”进行竞争。
09-12 08:27
Alnylam Pharmaceuticals shares are trading lower after the company announced the pricing of an upsized $575 million 0.00% convertible seniors due 2028.
Alnylam Pharmaceuticals shares are trading lower after the company announced th...
09-10 22:41
Alnylam prices $575M convertible senior notes
Alnylam Pharmaceuticals (NASDAQ:ALNY) priced its previously announced private offering of $575M aggregate principal amount of 0.00% convertible senior notes due 2028. The size of the offering was in...
09-10 13:49
Regeneron settles patent dispute with Sandoz over Eylea biosimilar
Sandoz (OTCQX:SDZNY) announced on Tuesday that Regeneron (NASDAQ:REGN) has agreed to settle a patent litigation related to a copycat version of Eylea, a blockbuster eye care medicine that the U.S. fir...
09-09 21:29
美联储下周要降息50基点？这八大降息交易方向值得关注！黄金已抢跑10%
美联储下周要降息50基点？这八大降息交易方向值得关注！黄金已抢跑10%，地产股、生物技术股、新兴市场等或将接棒>>
09-09 17:26
